Rising number of infectious diseases and immunological disorders, large-scale implementation of vaccination programs by global health agencies, technological advancements in vaccine storage equipment, rising R&D expenditure in biotechnological industries for vaccine research & storage, and rising government focus on immunization programs are some of the key factors driving the market’s growth.

Vaccines are sensitive biological substances that can lose their potency and effectiveness if they are exposed to temperatures outside the appropriate range, or when exposed to light. Therefore, to maintain the quality of vaccines they should be continuously kept within their determined temperature range from production to intended use. Vaccine storage equipment (such as refrigerators and freezers) plays a very important role in protecting individuals and communities from vaccine-preventable diseases.

https://meditechinsights.com/global-vaccine-storage-equipment-market/request-sample/

Proper storage and handling of vaccines begin with an effective vaccine “Cold Chain”. A cold chain is a temperature-controlled supply chain that includes all vaccine-related equipment and procedures. The cold chain begins with the cold storage unit at the manufacturing plant, extends to the transport and delivery of the vaccine and proper storage at the provider facility, and ends with the administration of the vaccine to the patient. If the cold chain is not properly maintained, vaccine potency may be lost, resulting in extra doses for patients, increased costs for providers, and wastage of vaccine supply. To ensure the proper safety of vaccines, the following equipment is recommended:

help to save lives and prevent serious illnesses. They are recognized as one of the most effective public health interventions available today. Vaccination programs are among the most cost-effective ways to prevent disease. Currently, a large number of vaccination programs are run by international organizations (such as WHO, UNICEF, GAVI) as well as local governments across the globe. These organizations have created a significant network that works in close collaboration with World Bank, World Trade Organization (WTO), International Monetary Fund, CDC, AVAT, Africa Centres for Disease Control and Prevention (Africa CDC), African Vaccine Acquisition Trust (AVAT), and other key partners to monitor progress, identify changes needed to resolve bottlenecks, coordinate information, and manage vaccination status at a large scale. Some of the leading global programs include The Global Vaccine Action plan (GVAP), Immunization Program by UNICEF, Vaccines for Children (VFC), and COVAX Program among others.

ULT cold storage refers to freezers used mainly in the life sciences and clinical labs to store critical samples for long periods. While the standard household freezer can provide temperatures as cold as -20°C, ULT freezers offer temperatures between -40 to -86°C (-40°F to -186°F).  When Pfizer-BioNTech and Moderna announced the development of their COVID-19 vaccines that require ultra-cold storage at -70 °C to prevent degradation of mRNA-based covid vaccines, a newfound interest in ultra-cold storage started to rise.For instance,

These freezers can simultaneously store up to 3 million doses of vaccines requiring ultra-low temperatures up to -86°C and also increase the shelf-life of vaccines which is critical for global deployment. ULT freezers also have many other uses, such as the storage of tissue samples, enzymes, and other biological materials in laboratories. This increase in the usage of ultra-low temperature cold storage is expected to drive the vaccine storage equipment market.

The outbreak of the COVID-19 pandemic has created an urgent demand for vaccines all over the world. The emergence of COVID-19 has also disrupted routine vaccination programs across the world, with GAVI estimating that approximately 80 million children will be affected across at least 68 countries. COVID-19 vaccine products also impacted the types of vaccine storage units and temperature monitoring devices used to maintain the cold chain, including the use of ultra-cold storage as COVID-19 vaccines differ from those of other vaccines.

The initiatives taken by the government organizations have triggered a race among leading drug-makers and research institutes to develop a Covid-19 vaccine at the earliest which in turn is expected to increase the demand for vaccine storage equipment in the future. For instance,

https://meditechinsights.com/global-vaccine-storage-equipment-market/request-sample/

The lack of storage infrastructure is the most basic challenge in developing countries, typically in the areas of operational efficiency, planning, talent availability, transportation, and warehousing infrastructure, as well as data systems and governance models. Currently, existing cold-chain capacity within developing countries is largely geared for the 2 to 8°C temperatures required for most routine immunization vaccines. Adding ultra cold chain storage to the system will require significant funding, and the ability for multiple countries to procure sufficient freezers simultaneously, also it would require significant expertise to install correctly and conduct capability building in operations staff to ensure proper and safe handling.

Some of the key/promising players operating in the vaccine storage equipment market include AmerisourceBergen Corporation, Arctiko A/S, B Medical Systems, Biobase Biodusty, Fiocchetti, Dulas Ltd, Eppendorf AG, EVERmed Srl, UL, Helmer Scientific Inc., Labcold Limited, PHC Holdings Corporation, Philipp Kirsch GmbH, Qingdao Haier Biomedical Co., Sartorius, Thermo Fisher Scientific Inc., Vestfrost Solutions, Antylia Scientific, and American Biotech Supply, among others.

The vaccine storage equipment market is a growing market marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as collaborations and acquisitions, to garner market share.  For instance,

The global vaccine storage equipment market is a growing market that is expected to gain further momentum in the coming years due to an increase in the development of smart technology, a favorable regulatory landscape, increasing investments from the government globally, and aggressive organic and inorganic growth strategies followed by the players.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 [email protected]